We are live on
!
Find out more
EAM
EFG Asset Management Portfolio holdings
AUM
$773M
1-Year Est. Return
40.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.47%
1 Year Est. Return
+40.1%
3 Year Est. Return
+211.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$445M
AUM Growth
+$12.5M
(+2.9%)
Cap. Flow
+$42M
Cap. Flow
% of AUM
9.43%
Top 10 Holdings %
Top 10 Hldgs %
17.71%
Holding
180
New
7
Increased
57
Reduced
108
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra Semiconductors
USD
|
+$52.1M |
| 2 |
Verisk Analytics
VRSK
|
+$3.82M |
| 3 |
Spotify
SPOT
|
+$3.29M |
| 4 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$2.15M |
| 5 |
Rocket Pharmaceuticals
RCKT
|
+$2.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$5.6M |
| 2 |
Edwards Lifesciences
EW
|
+$3.97M |
| 3 |
Align Technology
ALGN
|
+$2.59M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
+$1.57M |
| 5 |
Fate Therapeutics
FATE
|
+$1.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.46% |
| 2 | Technology | 20.4% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 6.73% |
| 5 | Financials | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
| $10.9M | 2.45% |
84,840
+5,134
| +6% | +$663K |
|
2
Idexx Laboratories
IDXX
$43B
| $10.6M | 2.37% |
25,712
-1,161
| -4% | -$451K |
|
3
Veeva Systems
VEEV
$30B
| $8.91M | 2% |
54,573
+1,213
| +2% | +$207K |
|
4
Intuitive Surgical
ISRG
$122B
| $7.4M | 1.66% |
27,649
-2,346
| -8% | -$572K |
|
5
Halozyme
HALO
$9.23B
| $7.1M | 1.59% |
124,572
-26,183
| -17% | -$1.34M |
|
6
Veracyte
VCYT
$4.63B
| $7.02M | 1.58% |
291,328
-5,205
| -2% | -$121K |
|
7
Alnylam Pharmaceuticals
ALNY
$35.6B
| $6.8M | 1.53% |
28,584
-170
| -0.6% | -$36.3K |
|
8
Ulta Beauty
ULTA
$20.8B
| $6.75M | 1.52% |
14,527
-2,313
| -14% | -$997K |
|
9
Apple
AAPL
$4.79T
| $6.73M | 1.51% |
51,898
-1,010
| -2% | -$144K |
|
10
DexCom
DXCM
$27.6B
| $6.7M | 1.5% |
59,751
-4,463
| -7% | -$490K |
|
11
KLA
KLAC
$280B
| $6.59M | 1.48% |
173,540
-28,110
| -14% | -$980K |
|
12
Deckers Outdoor
DECK
$14.2B
| $6.26M | 1.41% |
93,924
-5,148
| -5% | -$311K |
|
13
Xencor
XNCR
$1.45B
| $6.19M | 1.39% |
243,486
-9,091
| -4% | -$254K |
|
14
argenx
ARGX
$53.3B
| $5.83M | 1.31% |
15,522
-1,566
| -9% | -$586K |
|
15
Fair Isaac
FICO
$28.3B
| $5.52M | 1.24% |
9,178
-44
| -0.5% | -$23.2K |
|
16
Cheniere Energy
LNG
$56B
| $5.31M | 1.19% |
35,416
-1,894
| -5% | -$317K |
|
17
Natera
NTRA
$37.8B
| $5.27M | 1.18% |
129,597
+13,005
| +11% | +$536K |
|
18
IQVIA
IQV
$33.1B
| $5.13M | 1.15% |
24,703
+890
| +4% | +$181K |
|
19
Legend Biotech
LEGN
$4.55B
| $5.08M | 1.14% |
102,180
+11,052
| +12% | +$535K |
|
20
Dick's Sporting Goods
DKS
$18.8B
| $4.96M | 1.11% |
41,878
-2,320
| -5% | -$261K |
|
21
Illumina
ILMN
$28.9B
| $4.84M | 1.09% |
24,678
+79
| +0.3% | +$16.4K |
|
|
BPMC
22
DELISTED
Blueprint Medicines
BPMC
| $4.77M | 1.07% |
110,853
-4,141
| -4% | -$199K |
|
23
Trade Desk
TTD
$8.26B
| $4.7M | 1.06% |
103,752
+869
| +0.8% | +$44.1K |
|
24
Molina Healthcare
MOH
$11.6B
| $4.67M | 1.05% |
14,019
+2,504
| +22% | +$851K |
|
25
Palo Alto Networks
PANW
$273B
| $4.65M | 1.05% |
66,366
-11,780
| -15% | -$946K |
|
Similar funds
HWM
CP
BVDMP
MSAM
WA
PAS
NSEDCP
RAM
EFG Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, EFG Asset Management held 180 positions worth $445M, up 2.9% from $433M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
EFG Asset Management deployed $42M of net new capital in Q4 2022, opening 7 new positions and adding to 57 existing holdings. Its largest new stake was ProShares Ultra Semiconductors: 12,182,008 shares worth $3.05M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $5.6M trimmed.
- EFG Asset Management's largest Q4 2022 buy was ProShares Ultra Semiconductors: 12,182,008 shares worth $3.05M.
- EFG Asset Management added most to CoStar Group in Q4 2022, an estimated $1.08M increase.
- EFG Asset Management's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $5.6M.
- EFG Asset Management fully exited NEVRO CORP. in Q4 2022, selling an estimated $1.57M.
- EFG Asset Management's ten largest holdings make up 18% of its $445M portfolio in Q4 2022.
- EFG Asset Management opened 7 new positions and closed 8 in Q4 2022.
- EFG Asset Management's portfolio value rose 2.9% quarter-over-quarter to $445M.
Based on EFG Asset Management's 13F filing for Q4 2022, filed 3 Feb 2023.